papillary

Related by string. Papillary * * papillary thyroid cancer . papillary renal cell carcinoma . papillary RCC . papillary carcinoma . papillary thyroid carcinoma . papillary carcinoma form . papillary muscle . papillary tumors . muscle invasive papillary . papillary muscles *

Related by context. All words. (Click for frequent words.) 75 mucinous 74 endometrioid 73 nodular 73 pleomorphic 72 hyperplastic 72 neoplasm 72 sarcomatoid 72 pulmonary metastases 72 urothelial carcinoma 71 lung carcinomas 71 ductal 70 renal cell carcinomas 70 neoplasms 70 GISTs 70 pituitary adenomas 70 neurofibromas 70 epithelioid 70 carcinoma 70 carcinomas 70 adenocarcinomas 70 Histologically 70 squamous cell carcinoma SCC 70 lobular 69 paragangliomas 69 epithelial tumors 69 thyroid carcinoma 69 Papillary 69 neoplastic 69 papillomas 69 lymphocytic 69 hamartomas 69 intestinal metaplasia 69 chromophobe 68 gastric carcinoma 68 cell carcinoma 68 anaplastic 68 pancreatic adenocarcinoma 68 eccrine 68 squamous 68 histologic subtype 68 cervical lymph nodes 68 gastric adenocarcinoma 68 histologically 68 metachronous 68 hypoechoic 68 lymphadenopathy 68 papillary thyroid carcinoma 68 polypoid 68 lobular carcinoma 68 premalignant 68 ovarian carcinoma 67 tumoral 67 invasive ductal 67 urothelial 67 renal pelvis 67 cell carcinomas 67 renal tumors 67 HGPIN 67 breast carcinomas 67 cystic 67 lymphovascular invasion 67 osteosarcomas 67 parenchymal 67 lymph node metastases 67 dysplastic 67 hypointense 67 leiomyoma 67 meningiomas 67 leiomyomas 67 histopathologic examination 67 transitional cell carcinoma 67 malignant ovarian 66 neoplasias 66 lymph node metastasis 66 invasive carcinoma 66 lobular carcinomas 66 astrocytoma 66 breast carcinoma 66 hepatocellular carcinomas 66 Adenomas 66 malignant prostate 66 hamartoma 66 metaplasia 66 villous 66 prostate carcinoma 66 hypervascular 66 thyroid nodules 66 tumor xenograft models 66 extracranial 66 squamous cell carcinomas 66 invasive carcinomas 66 metastatic lesions 66 schwannomas 66 squamous carcinoma 66 histological subtype 66 Basal cell 66 nodal metastases 66 epithelial ovarian 65 Nodules 65 colorectal carcinoma 65 esophagogastric junction 65 MALT lymphoma 65 adenocarcinoma 65 bladder cancers 65 hyperintensity 65 precursor lesions 65 neoplastic lesions 65 Metastatic 65 Adenocarcinoma 65 Immunohistochemical staining 65 basal cell carcinomas 65 papillary carcinoma 65 PNET 65 cytokeratin 65 calculi 65 pheochromocytoma 65 resectable 65 follicular thyroid cancer 65 atypical hyperplasia 65 hyperechoic 65 node metastases 65 Metastases 65 adenomatous 65 colorectal neoplasms 65 seminomas 65 macules 65 histopathologic 65 thymoma 65 hematoxylin eosin original 65 carcinoids 65 neuroendocrine carcinoma 65 supratentorial 65 malignant lesions 65 situ LCIS 65 grade cervical intraepithelial 65 squamous cell cancers 65 invasive ductal carcinoma 65 histologic subtypes 65 sonographic findings 65 pheochromocytomas 65 nodular melanoma 64 adenoma 64 immunoreactivity 64 infiltrative 64 neoplasia 64 carcinoid tumor 64 nodal metastasis 64 Carcinoma 64 xenograft tumors 64 astrocytomas 64 submucosal 64 Squamous 64 periventricular 64 essential thrombocythemia 64 pT2 64 medullary 64 T2 weighted images 64 histologic findings 64 distant metastasis 64 Histologic 64 granulomas 64 malignant fibrous histiocytoma 64 FDG uptake 64 TIMP 64 proximal colon 64 carcinoid tumors 64 pT3 64 osteoid 64 papillary renal cell carcinoma 64 tonsillar 64 pathologic diagnosis 64 B Cell Lymphoma 64 noncalcified 64 gastric cancers 64 leiomyosarcoma 64 Endometrial 64 apocrine 64 liver metastasis 64 cytologically confirmed 64 endocervical 64 bladder tumors 63 gastrointestinal stromal tumor 63 Carcinomas 63 lipomas 63 Anaplastic 63 echogenic 63 pleural fluid 63 ADPKD 63 ductal cancer 63 T1a 63 anaplastic astrocytoma AA 63 carcinoid 63 situ DCIS 63 parenchyma 63 leukoplakia 63 endobronchial 63 metastatic lymph nodes 63 metastatic malignant 63 colorectal adenocarcinoma 63 melanocytic 63 cytologically 63 mRNA expression 63 intraepithelial 63 ductal breast cancer 63 echogenicity 63 hyperplasia 63 CIN3 63 cisplatin resistant 63 normal karyotype 63 fibroadenoma 63 Leydig cell 63 mesenteric 63 benign neoplasms 63 gastric cardia 63 aplasia 63 malignancies 63 histologic 63 premalignant lesions 63 immunohistochemical staining 63 papillary RCC 63 surgically resected 63 Figure 2C 63 histologically confirmed 63 Hurthle cell 63 Synovial sarcoma 63 malignant lymphoma 63 serous ovarian cancer 63 advanced adenoma 63 oligodendroglioma 63 malignant nodules 63 histologic examination 63 basal cell carcinoma BCC 63 axillary lymph nodes 63 hydronephrosis 63 hyperplastic polyps 63 granulomatous 63 pathologic 63 bullous 63 mediastinal 63 lymph node involvement 62 sonographically 62 fibroma 62 cellularity 62 papules 62 immunostaining 62 endometrial cancers 62 lymphocytosis 62 advanced adenomas 62 SLNB 62 thyroid nodule 62 peritumoral 62 lesions 62 osteochondroma 62 colorectal polyp 62 extranodal 62 squamous cell 62 polyposis 62 HER2 amplification 62 extracapsular extension 62 Sezary syndrome 62 nonmetastatic 62 lung nodules 62 lymphoid cells 62 lymphomas 62 differentiated thyroid 62 cutaneous melanoma 62 malignancy 62 choroidal 62 erythematous 62 grade gliomas 62 histological subtypes 62 cervical carcinoma 62 osteoblastic 62 sclerosing 62 Squamous cell 62 mesotheliomas 62 teratoma 62 perivascular 62 thyroglobulin 62 pancreatic prostate 62 lymph nodes spleen 62 resected 62 lymphoid 62 adenomatous polyps 62 hepatocellular 62 pericardial effusion 62 PCa 62 proximal tubule 62 stage IIIB 62 eosinophilic 62 urothelium 62 Diffuse Large B 62 thyroid carcinomas 62 oligodendrogliomas 62 fibroadenomas 62 radical nephrectomy 62 orthotopic 62 meningioma 62 morphologic 62 myxoid 62 pancreatic carcinoma 62 varices 62 paraganglioma 62 myeloproliferative disorder 62 transurethral resection 62 mesothelial cells 62 mesangial 62 histiocytes 62 histologies 62 immunohistochemical 62 uterine cervix 62 neuroendocrine tumors 62 cystic lesions 62 choroidal neovascularization CNV 62 poorer prognosis 62 atrophic 62 punctate 62 MGUS 62 NMIBC 62 pleural effusion 62 seminoma 62 intraepithelial neoplasia 62 extrahepatic 62 lymphoid tissue 62 ERBB2 62 clinicopathologic 62 ductal lobular 62 carcinoembryonic antigen 62 esophageal carcinoma 61 epididymal 61 Figure 1C 61 Carcinoid tumors 61 invasive lobular 61 PAOD 61 splenic 61 HBeAg negative 61 osteoid osteoma 61 Gliomas 61 leukocytosis 61 atypical ductal hyperplasia 61 neurofibroma 61 small lymphocytic lymphoma 61 myelofibrosis polycythemia vera 61 colorectal pancreatic 61 dysplasias 61 Uterine fibroids 61 TRAIL R1 61 progesterone receptor negative 61 myeloproliferative diseases 61 haematologic 61 tunica vaginalis 61 Hemangiomas 61 dysplastic lesions 61 malignant pancreatic 61 malignant growths 61 Leukemias 61 adrenocortical cancer 61 epithelia 61 peritoneal carcinomatosis 61 metastatic lesion 61 highly vascularized 61 malignant neoplasm 61 myeloid 61 myelomas 61 parotid 61 glomerular 61 hilar 61 esophageal squamous cell carcinoma 61 desmoplastic 61 metastatic carcinoma 61 hyperintense lesions 61 ccRCC 61 distant metastases 61 metastatic 61 contralateral breast 61 LNCaP 61 ductal carcinomas 61 HER2 receptor 61 situ CIS 61 malignant cancerous 61 Peritoneal 61 prostatic 61 EGFR mutant 61 metastases 61 Malignant 61 Melanomas 61 breast lesions 61 serum prostate 61 nevus 61 basal cell cancers 61 grade squamous intraepithelial 61 subependymal giant cell 61 melanocytic nevi 61 malignant polyps 61 prostatic adenocarcinoma 61 microsatellite instability 61 synovial 61 HRCT 61 histopathologic findings 61 CIN2 + 61 uveal melanoma 61 sinonasal 61 skeletal metastases 61 Glioblastomas 61 carcinoma HNSCC 61 submucosa 61 pancreatic neuroendocrine 61 renal cell carcinoma 61 ovarian lung 61 Histopathologic 61 histopathological 61 leukemia AML 61 Histological examination 61 papillary thyroid cancer 61 castration resistant 61 Cutaneous T 61 localized renal 61 basal cell 61 colorectal adenoma 61 tumors 61 cutaneous lesions 61 unresectable tumors 61 pulmonary metastasis 61 plasmacytoid 61 Polyps 61 brain parenchyma 61 granulosa cell 61 biochemical recurrence 61 CIN2 61 squamous cells 60 adrenocortical 60 Cell Lymphoma 60 neovascular 60 infarcts 60 SPINK1 60 KRAS wild 60 squamous cell cancer 60 Tumours 60 telangiectasia 60 necrotizing 60 mycosis fungoides 60 prostate carcinomas 60 prostate cancer CaP 60 metastatic gastric 60 primary effusion lymphoma 60 acute myeloid 60 haematopoietic 60 nasopharyngeal carcinoma 60 vestibular schwannomas 60 castrate resistant 60 eosin 60 colorectal liver metastases 60 papule 60 Squamous Cell Carcinoma 60 ependymomas 60 medullary thyroid cancer 60 ERalpha 60 lung adenocarcinomas 60 metastatic bladder 60 luminal 60 HNSCC 60 Lesions 60 nonmelanoma skin cancers 60 lymphadenectomy 60 HER2 expression 60 pancreatic ovarian 60 mononuclear cells 60 hematoxylin 60 interstitial fibrosis 60 thrombi 60 biopsy specimen 60 Precancerous 60 Ki# 60 Lymphomas 60 breast pancreatic 60 dysplasia 60 ischemic lesions 60 Barrett mucosa 60 Renal cell carcinoma 60 myometrium 60 urethral stricture 60 endometrial 60 sonographic appearance 60 xenografts 60 colorectal gastric 60 dysplastic nevi 60 pancreatic lung 60 extramedullary 60 papillae 60 infiltrating ductal carcinoma 60 choroidal neovascularization 60 intestinal polyps 60 grade dysplasia 60 neuroblastomas 60 axillary 60 gastroduodenal 60 papular 60 wedge resection 60 mononuclear 60 malignant 60 metastatic malignant melanoma 60 neuroendocrine cancers 60 elevated LDH 60 parathyroid carcinoma 60 geographic atrophy 60 BRCA deficient 60 appendiceal 60 neointimal 60 underwent resection 60 pancreatic endocrine 60 ductal adenocarcinoma 60 colorectum 60 prognostic significance 60 BRAF mutations 60 ipsilateral 60 noncancerous cells 60 lymphoproliferative disorders 60 mediastinal lymph nodes 60 locoregional 60 fallopian tube cancers 60 ANCA associated 60 Glioma 60 biliary tract 60 colorectal tumors 60 explants 60 hypopigmentation 60 hormone receptor negative 60 colon carcinoma 60 Sjögren syndrome 60 endometrial carcinoma 60 cholelithiasis 60 mitomycin C 60 axilla 60 intrahepatic 60 isoenzyme 60 lobular breast cancer 60 p# mutations 60 immunohistochemical analysis 60 lymphopenia 60 submandibular 60 K ras mutations 60 hypopharynx 60 Cysts 60 basal cell skin 60 cytoreduction 60 prostate adenocarcinoma 60 Basal Cell 60 scintigraphic 60 nonproliferative 60 GSTP1 60 chest radiography 60 lichen planus 60 CYT# potent vascular disrupting 60 angiosarcoma 60 pituitary adenoma 60 collagenous 60 ascites 60 gadolinium enhanced 60 colorectal carcinomas 60 soft tissue sarcomas 60 EGF receptors 60 hematologic toxicity 60 micrometastases 60 cerebrospinal fluid CSF 60 pseudoaneurysm 60 nonalcoholic steatohepatitis NASH 59 pathologic examination 59 EGFR HER2 59 Barrett esophagus BE 59 membranous 59 tracheobronchial 59 sepal 59 Medullary thyroid cancer 59 pancreatic gastric 59 lymphoid organs 59 lymphoma subtypes 59 CIN3 + 59 Squamous cell carcinomas 59 colonic polyps 59 seborrheic keratoses 59 promoter methylation 59 urine cytology 59 precancers 59 synovium 59 EpCAM 59 hepatocellular carcinoma 59 CD# expression [001] 59 lung pancreatic 59 pre cancerous 59 stage IIIA 59 intralesional 59 hypoperfusion 59 peritoneal fluid 59 alkaline phosphatase 59 endometrial hyperplasia 59 acinar 59 B7 H3 59 Mesenchymal 59 glomerulonephritis 59 NP CRNs 59 Nasal polyps 59 basal cell cancer 59 Immunohistochemical analysis 59 biliary tract cancer 59 hepatoma 59 liver metastases 59 locoregional recurrence 59 lymphoid malignancies 59 seminal vesicle 59 Doppler sonography 59 renal carcinoma 59 medically inoperable 59 prostatic tissue 59 cervical intraepithelial neoplasia 59 chromosomal rearrangement 59 mesothelial 59 ultrasonographic 59 imatinib resistant 59 prostate pancreatic 59 bronchogenic carcinoma 59 neurological manifestations 59 atypia 59 hyperintensities 59 hepatocellular cancer 59 axillary lymph node 59 hepatic metastases 59 myoepithelial 59 TRUS 59 lobular cancer 59 ^ sup #m 59 lymphocytic leukemia 59 perianal 59 unresectable 59 occlusive disease 59 malignant neoplasms 59 pCR 59 Stomatitis 59 ASCUS 59 surgical excision 59 adenomyosis 59 tumor xenografts 59 sentinel nodes 59 constitutively active 59 carcinoma HCC 59 prostatic hyperplasia 59 inguinal 59 metastatic neuroendocrine tumors 59 osteopetrosis 59 endoscopic ultrasonography 59 anterior uveitis 59 urothelial cancer 59 total thyroidectomy 59 fallopian tube carcinoma 59 cell lymphoma ALCL 59 ovarian tumors 59 pleura 59 adrenal cortex 59 lobule 59 situs inversus 59 metastatic prostate 59 subcortical 59 activating mutation 59 hypertrophic scars 59 liposarcoma 59 SUVmax 59 morphologic characteristics 59 malignant tissue 59 hyperkeratosis 59 pre cancerous lesion 59 Meningiomas 59 retroperitoneal 59 activating mutations 59 lung ovary 59 duodenal 59 benign tumors 59 EGFR mutations 59 diverticula 59 operable breast cancer 59 lung metastases 59 opacification 59 Supplementary Fig 59 TUNEL 59 malignant pleural mesothelioma 59 ocular melanoma 59 primitive neuroectodermal tumor 59 follicular lymphomas 59 molecular subtypes 59 trophoblasts 59 T1c 59 HER2 overexpression 59 metastatic renal 59 intracranial tumors 59 hypoplasia 59 fungoides 59 PCNSL 59 endometrial adenocarcinoma 59 tumors GIST 59 CLL SLL 59 benign nodules 59 neoplastic cells 59 rectal cancers 59 JMML 59 oesophageal 59 precancerous cervical 59 Follicular Lymphoma 59 Prostatic 59 anaplastic astrocytoma 59 sarcomas 59 metastatic GIST 59 alveolar epithelial cells 59 Figure 1A 59 Brain metastases 59 ALK mutations 59 blebs 59 atherosclerotic lesions 59 leukemias lymphomas 59 adventitia 59 basal cells 59 radiosensitivity 59 squamous cell carcinoma 59 fibrin deposition 59 glutamyl 59 intravesical therapy 59 benign moles 59 recurrent NSCLC 59 Histological 59 PC# cells 59 mesothelium 59 BPH benign prostatic 59 surgically resectable 59 purpura 59 mucosal lesions 59 Histopathologic examination 59 radiochemotherapy 59 Neoplasms 59 solar keratosis 58 vulvar intraepithelial neoplasia 58 nanomolar 58 immunoreactive 58 serrated polyps 58 invasive ductal carcinomas 58 VEGFR1 58 lactate dehydrogenase 58 ovarian pancreatic 58 plexiform neurofibromas 58 cell sarcoma 58 overexpress 58 squamous cell lung cancer 58 Upregulation 58 nodules 58 specific antigen PSA 58 DR4 58 seminal vesicle invasion 58 radiographic findings 58 TIMP 1 58 intraductal 58 interstitium 58 Glioblastoma Multiforme 58 biliary strictures 58 proliferative diabetic retinopathy 58 malignant tumors 58 micronuclei 58 benign lesions 58 tumor histology 58 prostate bladder 58 neuroblastoma tumors 58 demyelinating 58 schwannoma 58 Toxicities 58 null mice 58 fibromatosis 58 lymph node enlargement 58 squamous cell skin 58 proto oncogene 58 thyrotoxicosis 58 V#F mutation 58 squamous epithelium 58 malignant transformation 58 hyperintense 58 mosaicism 58 lymphatic tissue 58 sentinel lymph nodes 58 lung metastasis 58 completely resected 58 cell lymphomas 58 Basal cell carcinoma 58 hematuria 58 HER2 positive tumors 58 underwent surgical resection 58 cutaneous squamous cell carcinoma 58 etiologies 58 tubule 58 benign noncancerous 58 epithelial cancers 58 lobules 58 pleural effusions 58 androgen receptor AR 58 lesional 58 nonmalignant 58 Trichophyton rubrum 58 basilar 58 transabdominal 58 ovarian breast 58 nonmelanoma 58 reflux esophagitis 58 carcinomatosis 58 node metastasis 58 fibrosarcoma 58 Refractory Hodgkin Lymphoma 58 T Cell Lymphoma 58 diverticular 58 haematuria 58 ethmoid 58 HepG2 cells 58 glioblastoma multiforme GBM 58 penetrance 58 bone marrow lymph nodes 58 transmural 58 immunofluorescence staining 58 astrocytic 58 prognostic indicator 58 germline mutations 58 Hashimoto thyroiditis 58 hepatocellular carcinoma HCC 58 gastrointestinal stromal tumors 58 meningeal 58 calcifications 58 umbilical vein 58 descending thoracic aorta 58 choriocarcinoma 58 LVNC 58 transgene expression 58 thyroid cancers 58 sonographic 58 adjuvant radiotherapy 58 TMPRSS2 ERG 58 Duodenal 58 pseudotumor 58 transvaginal sonography 58 hepato 58 T#I mutant 58 goblet cells 58 MDA MB 58 anaplastic astrocytomas 58 lymphangiogenesis 58 HER2 negative 58 dysplastic lesions caused 58 focally 58 chest radiograph 58 ALCL 58 Mutational 58 tricuspid regurgitation 58 osteochondromas 58 stomach duodenum 58 nonsmall cell lung cancer 58 cytopenias 58 TOP2A gene 58 nucleated cells 58 homozygotes 58 anterior temporal 58 myofibroblasts 58 PSADT 58 parathyroid 58 immunocompetent 58 cytogenetic abnormalities 58 esophageal cancers 58 polypoid lesions 58 carotid stenosis 58 bladder carcinoma 58 keloid 58 radical prostatectomy RP 58 stenoses 58 seminal vesicles 58 histologically proven 58 keratoses 58 cell adhesion molecules 58 chemoresistant 58 axillary nodes 58 Activating mutations 58 vimentin 58 idiopathic PAH 58 epithelial cell 58 HER2 + 58 superficial basal cell carcinoma 58 thymectomy 58 NSCLC tumors 58 steroidogenesis 58 histological diagnosis 58 Asymptomatic 58 anal canal 58 lung nodule 58 acute GvHD 58 lymphoblasts 58 prostate cancer PCa 58 follicular lymphoma FL 58 pancreatic ducts 58 pancreatic colon 58 oncoproteins 58 diabetes mellitus DM 58 MYCN amplification 58 biopsy specimens 58 cholangiocarcinoma 58 synovial tissue 58 chondrosarcoma 58 IGF1R 58 luteinizing hormone releasing 58 PC3 cells 58 hypoplastic 58 ependymoma 58 HLA DR 58 rebleeding 58 Sarcomas 58 IV NSCLC 58 lytic 58 FOLFOX6 58 ERK signaling 58 metastatic pancreatic 58 Helicobacter pylori infection 57 ureteric 57 phosphoprotein 57 bacteriuria 57 gliomas 57 RASSF1A 57 pericardial effusions 57 SSc 57 ErbB2 positive 57 colorectal cancer CRC 57 polycythemia vera PV 57 BRAF V#E 57 uterine tumors 57 MLH1 57 Acute lymphoblastic leukemia 57 neoadjuvant therapy 57 androgen dependent 57 adenomatous polyp 57 hormone secreting 57 cytological 57 Relapsed Refractory 57 essential thrombocythemia ET 57 severe neutropenia 57 multicentric 57 plexiform 57 Castration Resistant Prostate Cancer 57 CD# CD# 57 P. gingivalis 57 brain metastases 57 MAPK pathway 57 calcified plaques 57 breast cancer subtypes 57 PTHrP 57 myxoma 57 Supplemental Figure 57 clinicopathological 57 lung tumors 57 edematous 57 PI3K Akt 57 metastatic tumors 57 cytologic 57 TP# mutations 57 aberrant activation 57 Dysplasia 57 N. gonorrhoeae 57 Nodular 57 adenomas 57 pilocytic astrocytoma 57 Circulating tumor cells 57 lactate dehydrogenase LDH 57 prognostic factors 57 #.#ng/ml 57 precancerous condition 57 epididymitis 57 Ductal carcinoma 57 gastric pancreatic 57 chronic lymphocytic 57 GBM tumors 57 Endometrial cancer 57 metastatic basal cell 57 demyelination 57 endocrine tumors 57 lateral ventricle 57 microcalcifications 57 hypothalamic pituitary 57 Progenitor Cells 57 CD#c 57 T2 weighted MRI 57 rs# [002] 57 stroma 57 EGFr 57 tubules 57 hypertrophic scarring 57 malignant lymphomas 57 hypereosinophilic syndrome 57 RECIST Response Evaluation Criteria 57 bronchoalveolar lavage 57 hypercalcemia 57 cytogenetic responses 57 recurrent metastatic 57 fine needle aspiration 57 GNAQ

Back to home page